WPRIM Management System> DCMS> Journal of Experimental Hematology> 2013> 21> 2

Volume: 21 Issue: 2

1. Effects of eEF1A1 re-expression on proliferation and apoptosis of Jurkat cells with knocked down eEF1A1 gene and its mechanisms. Page:279—284
2. Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia. Page:273—278
3. Effects of Rheb overexpression in HL-60 and K562 leukemia cell lines. Page:268—272
4. Concept of mesenchymal stem cells: bring more insights into functional research of MSC. Page:263—267
5. Effect of methylation inhibitor in the treatment of leukemia. Page:536—538
6. Advances of studies on pathogenesis and management of paroxysmal nocturnal hemoglobinuria. Page:530—535
7. Research progress of novel porous hemostatic agents. Page:526—529
8. Advances in immunotherapy of hematological malignancies by using chimeric antigen receptor-modified lymphocytes. Page:521—525
9. Role of signal transducer and activator of transcription 3 in the development of tumors. Page:517—520
10. Progress in biochemical characteristics of hemopexin and its clinical application. Page:513—516
11. Research advances of anti-CD40 monoclonal antibody. Page:508—512
12. Research progress of N-Myc roles in hematopoiesis and hematologic malignancies. Page:503—507
13. EB virus-associated lymphoproliferative disorders and cytokine storm. Page:498—502
14. Correlation of Eps8 with proliferation, metastasis and prognosis of malignant tumors. Page:493—497
15. Ex vivo expansion of human hematopoietic stem/progenitor cells by TAT-HOXB4 homeoprotein and the prospect of its clinical use. Page:489—492
16. Current understanding of iron overload hazard in patients with myelodysplastic syndrome. Page:484—488
17. Expression of endothelial nitric oxide synthase mRNA in human RBCs during storage. Page:481—483
18. Serologic and molecular biological detection of rare B(A) blood group. Page:478—480
19. Detection of weak D antigen by flow cytometry. Page:474—477
20. Changes of FoxP3, CD4(+)CD25(+) regulatory T cells, TLR2 and TLR9 in children with infectious mononucleosis. Page:469—473
21. Detection of serum neopterin in patients with hemophagocytic lymphohistiocytosis and its significance. Page:465—468
22. Clinical analysis of Epstein-Barr virus-associated hemophagocytic syndrome in children. Page:460—464
23. Inhibitory effect of human umbilical cord-derived mesenchymal stem cells on interleukin-17 production in peripheral blood T cells from spondyloarthritis patients. Page:455—459
24. Efficient isolation of mesenchymal stem cells from human bone marrow by direct plating method combined with modified primary explant culture. Page:451—454
25. Hematopoietic potential of Flk-1(+) populations in mouse embryonic AGM region. Page:446—450
26. Clinical research of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma. Page:441—445
27. Quantitative monitoring of multi-donor chimerism after multi-donor allogeneic hematopoietic stem cell transplantation. Page:436—440
28. Changes of Th1/Th2/Th17 in patients received non-myeloablative haploidentical hematopoietic stem cell transplantation detected by flow cytometric bead array. Page:431—435
29. Therapeutic efficacy evaluation of rabbit anti-thymocyte globulin combined with cyclosporine A in children with aplastic anemia. Page:426—430
30. Construction and significance of recombinant hF9 minigene and its stable nonsense mutant cell lines. Page:422—425
31. Clinical significance of Helicobacter pylori in children with idiopathic thrombocytopenic purpura. Page:419—421
32. Correlation of chromosome karyotype with dyshaematopoiesis and reticulin in myelodysplastic syndrome. Page:415—418
33. Significance of low molecular weight urinary protein for assessment of early renal damage in patients with multiple myeloma. Page:410—414
34. Peripheral blood monocyte hepcidin in patients with multiple myeloma is associated with anemia of chronic disease. Page:403—409
35. Clinical analysis of 10 patients with de novo CD5 positive diffuse large B cell lymphoma. Page:399—402
36. Expression and significance of p53-inducible gene 3 (PIG-3) in diffuse large B cell lymphoma. Page:396—398
37. The role of cytokines in lymphoma with anemia. Page:392—395
38. Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma. Page:387—391
39. Expressions of VEGF and CXCR4 in diffuse large B cell lymphoma and their clinical significances. Page:383—386
40. Analysis of clinical characteristics and prognostic factors of primary mediastinal T-cell lymphoblastic lymphoma. Page:377—382
41. Immunophenotype analysis of leukemic mantle cell lymphoma. Page:371—376
42. Expression of PD-L1 in lymphoma and its effect on lymphoma proliferation and chemotherapy resistance. Page:366—370
43. Effect of phenylhexyl isothiocyanate on Wnt/beta-catenin signaling pathway in Jurkat cell line. Page:361—365
44. Effects of decitabine on proliferation and apoptosis of NB4 and K562 cells. Page:356—360
45. 2-DG enhances TRAIL-induced apoptosis of leukemia HL-60 cells. Page:351—355
46. Mechanism for clofarabine inducing autophagic death of acute myelocytic leukemia cell U937. Page:347—350
47. Effect of valproic acid sodium on proliferation and apoptosis of acute T-lymphoblastic leukemia Jurkat cells. Page:343—346
48. Dynamically monitoring minimal residual disease in acute leukemia after complete remission by multiparameter flow cytometry and its relation with prognosis. Page:339—342
49. NVP-BEZ235 inhibits proliferation and colony-forming capability of CD34(+)CD38(-) human acute myeloid leukemia stem cells. Page:334—338
50. Ratio balance of Th17 and Treg cells in peripheral blood of patients with chronic lymphocytic leukemia. Page:329—333
51. Expression of osteopontin in central nervous system leukemia and its clinical significance. Page:325—328
52. Expression of IGF-IR and IR in children with acute lymphoblastic leukemia. Page:320—324
53. Expression of SALL4 gene in patients with acute and chronic myeloid leukemia. Page:315—319
54. Pathological characteristics of leukemia patients with secondary myelofibrosis and their relationship with the prognosis of disease. Page:311—314
55. Clinical analysis of acute myeloid leukemia with CBFB-MYH11-positive. Page:305—310
56. Abnormality of blood coagulation indexes in patients with de novo acute leukemia and its clinical significance. Page:300—304
57. Overexpression of eIF4E gene in acute myeloid leukemia and its relation with disease progression. Page:296—299
58. Characteristics of 4 specific target antigens in adult acute lymphoblastic leukemia. Page:289—295
59. Correlation of HLA-A, B, DRB1 genes with leukemia. Page:285—288